No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
DENTSPLY SIRONA Inc. is a global provider of diverse dental solutions, offering a comprehensive range of products and technologies to the professional dental industry across the globe. Its operations are segmented into two primary divisions: Technologies & Equipment, and Consumables. The Technologies & Equipment division delivers sophisticated dental apparatus, including treatment chairs, advanced imaging systems, powered handpieces, and other specialized tools for dental professionals. It also encompasses dental CAD/CAM systems that facilitate a variety of digital dental processes like restorations within clinics. This segment features both professional (SureSmile) and direct-to-consumer clear aligner offerings, alongside high-frequency vibration technology devices and dental implants. Furthermore, it supplies urology catheters and other healthcare-related consumable items. The Consumables division focuses on products essential for dental practice. This includes endodontic supplies such as drills, files, sealers, irrigation needles, and single-use tools vital for root canal treatments. It also provides restorative materials like prosthetic teeth, dental ceramics, digital dentures, high-quality metal dental alloys, and porcelain for crowns and bridges. Additionally, this segment offers compact equipment, including intraoral curing lights, diagnostic systems, and ultrasonic scalers/polishers, as well as a range of anesthetics, prophylaxis pastes, sealants, impression materials, teeth whitening solutions, and topical fluoride applications. Established in 1877, the company maintains its corporate headquarters in Charlotte, North Carolina.
www.dentsplysirona.comNo one on the platform currently holds 0I8F.L.
No tracked institution reports a position in 0I8F.L as of their last filing.
No one on the platform has traded 0I8F.L yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | -3.0% | 1.9% | ||||
| Profit Margin % | -16.3% | -11.6% | -10.7% | |||
| Free Cash Flow Margin % | 2.8% | 7.5% | 9.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.6B | -2.0% | $1.53 | $1.50–$1.55 | — | 1 |
| 2027 | $3.6B | +1.7% | $1.52 | $1.49–$1.54 | — | 1 |
| 2028 | $3.7B | +2.9% | $1.68 | $1.65–$1.71 | — | 1 |
| 2029 | $3.8B | +1.8% | $1.71 | $1.68–$1.74 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $0.35 | $0.52 | +49.4% |
| 2026-05-05 | $0.28 | $0.27 | -2.7% |
| 2026-02-26 | $0.28 | $0.27 | -2.7% |
| 2025-11-06 | $0.45 | $0.37 | -17.4% |
| 2025-08-07 | $0.51 | $0.52 | +2.8% |
| 2025-05-08 | $0.30 | $0.43 | +45.2% |
| 2025-02-27 | $0.43 | $0.26 | -39.1% |
| 2024-11-07 | $0.47 |
| $0.50 |
| +5.5% |
| $1.5B |
| — |
| 0JBU.LIntellia Therapeutics, Inc. | $11.58 | +1.05% | $1.3B | — |
| 0K1R.LViridian Therapeutics, Inc. | $21.89 | +1.39% | $2.0B | — |
Source: Financial Modeling Prep · peers by sector/industry